Emmaus Life Sciences, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Baker Tilly, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 USD | 0.00% | -2.91% | -0.10% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.10% | 6.39M | |
+44.48% | 55.07B | |
+44.53% | 40.22B | |
-0.86% | 41.79B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- EMMA Stock
- News Emmaus Life Sciences, Inc.
- Emmaus Life Sciences, Inc. Auditor Raises 'Going Concern' Doubt